News

Our news cover the latest topics from the past 30 days, as retrieved from Chinese-language press releases and other information sources.

For older news topics, please use the archive button.

Please use the search module to retrieve information on institutes, researchers and research topics

 

China’s National Institute of Metrology (NIM) develops monoclonal antibody reference material for COVID-19, and antibody and nucleic acid test kits from China are already being exported

Since the outbreak of the epidemic, immunoassays based on IgM antibody and IgG antibody of the COVID-19 patients have become an important supplement to nucleic acid-based detection. 

Two new antibody reference materials developed by the NIM were now approvaed as national reference materials by the State Administration for Market Regulation.

As of March 16, a total of 11 nucleic acid detection reagents and eight antibody detection reagents for the COVID-19 were approved in China. According to a report by Japan’s Nikkei Biotech, some test kits developed by Tsinghua University, Sichuan University, Xiamen University, Xiamen University of Technology and Chongqing Medical University have already received CE certification and are exported to more than 10 countries, including Italy, the United Kingdom and the Netherlands.

Xinhua news release, March 23, 2020

Nikkei Biotech news release, March 18, 2020

CMDA approves test chip for multiple respiratory viruses

The virus chip was jointly developed by West China Hospital affiliated to Sichuan University, Tsinghua University and a Chengdu-based biotech company, Boao Jingxin Biotechnology Co. With secretion samples collected from patients' noses and throats, the chip...

read more

China invests heavily in 5G infrastructure

According to the China Academy of Information and Communications Technology (CAICT), China expects over 550,000 5G base stations to be put in operation by the end of 2020. Prefecture-level cities are expected to achieve continuous outdoor connection of the 5G network...

read more